About Retatrutide
Retatrutide is studied as a multi-receptor agonist targeting GIP, GLP-1, and glucagon receptors, and is used in laboratory research focused on complex metabolic signaling. It is supplied as a lyophilized powder for investigations into receptor pharmacology, energy metabolism pathways, and glucose regulation mechanisms in controlled experimental models. Each batch is verified for identity and purity using HPLC and mass spectrometry. Supplied as: Lyophilized powder Purity: >95-99 (HPLC verified) Storage: Store desiccated at ?20�C for long-term. Short-term room temperature exposure (around 1 month) during shipping/handling is generally acceptable if kept sealed, dry, and protected from heat/light. Designation: FOR RESEARCH USE ONLY. Not intended for human or animal consumption.
Latest Research
Retatrutide and the urinary tract infection signal: Is the answer hidden in timing?
Recent research on Retatrutide: Retatrutide and the urinary tract infection signal: Is the answer hidden in timing?
Read Full Study on PubMedMedical Treatments for Obesity: What Does the Future Have in Store?
Recent research on Retatrutide: Medical Treatments for Obesity: What Does the Future Have in Store?
Read Full Study on PubMedAdditional Studies
Retatrutide fact check: Has a man died after taking the unapproved weight loss jab?
Recent research on Retatrutide: Retatrutide fact check: Has a man died after taking the unapproved weight loss jab?
Read on PubMedComparative effects of drugs for adults with overweight or obesity: systematic review and network meta-analysis.
Recent research on Retatrutide: Comparative effects of drugs for adults with overweight or obesity: systematic review and network meta-analysis.
Read on PubMedEffects of retatrutide on learning and memory in streptozotocin-induced male diabetic rats.
Recent research on Retatrutide: Effects of retatrutide on learning and memory in streptozotocin-induced male diabetic rats.
Read on PubMedEffect of Retatrutide, a Novel Triple Receptor Agonist, on Blood Pressure and Lipid Levels: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Recent research on Retatrutide: Effect of Retatrutide, a Novel Triple Receptor Agonist, on Blood Pressure and Lipid Levels: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Read on PubMedEfficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 trial.
Recent research on Retatrutide: Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blin
Read on PubMedA Hydrophobic Tag-Assisted Liquid-Phase Strategy for the Synthesis of Retatrutide.
Recent research on Retatrutide: A Hydrophobic Tag-Assisted Liquid-Phase Strategy for the Synthesis of Retatrutide.
Read on PubMedRelated Research
Purchase Retatrutide from Verified Peptides
High-purity research peptides with full analytical verification
- 99% Purity (HPLC Verified)
- Full Certificate of Analysis
- Same Day Dispatch
- Free UK Shipping Over £75
Research Disclaimer
The research articles and studies referenced on this page are for informational purposes only. All products are sold for research use only and are not intended for human or animal consumption. The information provided does not constitute medical advice, diagnosis, or treatment. Always consult with qualified healthcare professionals before making any decisions related to health or medical treatment.